Who owns Atyr Pharma Inc?
- Ticker: LIFE
- CUSIP Number: 002120202
Tip: Access positions for across all investors
Analyze quarterly positions in Atyr Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Atyr Pharma stock
Who bought or sold Atyr Pharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Federated Investors | 10M | $14M | 0% | Dec 2023 |
|
| Logos Global Management | 5.9M | $8.2M | 100% | Dec 2023 |
|
| Alyeska Investment Group | 2.5M | $3.5M | 0% | Dec 2023 |
|
| Vanguard Group | 2.4M | $3.3M | 4% | Dec 2023 |
|
| Citadel Advisors | 1.8M | $2.5M | -2% | Dec 2023 |
|
| Checkpoint Capital | 1.5M | $2.1M | 100% | Dec 2023 |
|
| Tang Capital Management | 471k | $664k | 0% | Dec 2023 |
|
| GSA Capital Partners | 224k | $437k | 105% | Mar 2024 |
|
| Dimensional Fund Advisors | 197k | $384k | 38% | Mar 2024 |
|
| Bank of America Corporation | 149k | $210k | 128141% | Dec 2023 |
|
| Two Sigma Advisers | 148k | $208k | -22% | Dec 2023 |
|
| Goldman Sachs Group | 144k | $202k | 100% | Dec 2023 |
|
| Millennium Management | 125k | $177k | 49% | Dec 2023 |
|
| Squarepoint Ops | 120k | $168k | -15% | Dec 2023 |
|
| Royal Bank of Canada | 91k | $0 | 13% | Dec 2023 |
|
| Barclays | 79k | $111k | 100% | Dec 2023 |
|
| Citigroup | 79k | $153k | 0% | Mar 2024 |
|
| Kingswood Wealth Advisors | 60k | $117k | 100% | Mar 2024 |
|
| Y-Intercept | 44k | $86k | 100% | Mar 2024 |
|
| Main Street Financial Solutions | 35k | $67k | 100% | Mar 2024 |
|
| Farther Finance Advisors | 30k | $43k | 100% | Dec 2023 |
|
| SG Americas Securities | 28k | $55k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 27k | $52k | 0% | Mar 2024 |
|
| Two Sigma Investments | 27k | $37k | -71% | Dec 2023 |
|
| Virtu Financial | 26k | $37k | 93% | Dec 2023 |
|
| CTC Alternative Strategies | 18k | $34k | 100% | Mar 2024 |
|
| Cubist Systematic Strategies | 18k | $25k | 47% | Dec 2023 |
|
| UBS Group | 16k | $23k | 273% | Dec 2023 |
|
| D.A. Davidson & Co. | 13k | $18k | -44% | Dec 2023 |
|
| Jpmorgan Chase & Co | 12k | $17k | -76% | Dec 2023 |
|
| Actinver Wealth Management | 10k | $20k | 0% | Mar 2024 |
|
| Simplex Trading | 6.0k | $11k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 1.9k | $3.7k | 0% | Mar 2024 |
|
| PFS Partners | 340.00 | $663.000000 | 0% | Mar 2024 |
|
| Caldwell Sutter Capital | 52.00 | $100.999600 | 0% | Mar 2024 |
|
Who sold out of Atyr Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Man Group | Sep 2023 | 421k | $666k |
| Granite Bay Wealth Management | Dec 2023 | 18k | $22k |
| Bank of New York Mellon | Dec 2023 | 16k | $23k |
| Wolverine Trading | Sep 2023 | 11k | $17k |